Mechanisms of spatiotemporal signaling by GPCRs

GPCR 的时空信号传导机制

基本信息

项目摘要

Project Summary G protein-coupled receptors (GPCRs) comprise the largest family of signaling receptors in animals, and as such, they represent an important class of therapeutic targets. Following ligand binding and G protein activation at the plasma membrane, GPCRs undergo regulated endocytosis and sorting for recycling or degradation. Traditionally, studies of ligand-dependent GPCR signaling have focused on receptor-G protein coupling at the plasma membrane (PM). However, it is now clear that GPCRs can continue to signal from internal membrane locations and that the downstream responses elicited from intracellular signaling are distinct from those elicited from PM signaling. While the biochemistry of GPCR activation has been studied in detail, the organization and regulation of GPCR signaling in living cells remains an underexplored frontier. The proposed studies will investigate fundamental mechanisms underpinning spatiotemporal regulation of GPCR signaling and will provide key training to enable Dr. Blythe to become an independent leader in this emerging area of molecular and cellular physiology. The mentored phase of this project will be carried out at the University of California, San Francisco under the primary mentorship of Dr. Mark von Zastrow, a leader in the field of GPCR trafficking and signaling. The long-term goals of this work are to understand (1) how the subcellular localization of GPCRs and their associated proteins change in response to signaling and (2) how this cellular reorganization regulates their distinct downstream responses. The first two Aims will focus on receptor trafficking and signaling, defining the mechanisms by which unique endocytic (Aim 1) and recycling (Aim 2) pathways sculpt signaling by endogenously expressed GPCRs in a HEK293 cell model. In carrying out these experiments, Dr. Blythe will gain new experience in advanced imaging techniques, as well as in integral membrane protein biochemistry with the help of Dr. Aashish Manglik (collaborator). Aim 3 frames the biology in a broader perspective by asking how the dynamic subcellular localization of other proteins contributes to the spatiotemporal regulation of GPCR signaling. Using a novel proximity labeling approach under the mentorship of Dr. Nevan Krogan (co-Mentor) and Dr. Ruth Hüttenhain (collaborator), Dr. Blythe will map the changes in the proteomes of specific cellular compartments during the activation of the same model GPCRs and explore how these changes dictate signaling. The proposed work will enable a systems-level analysis of GPCR signaling that was not feasible with current approaches and provide an invaluable training opportunity for Dr. Blythe in mass spectrometry-based proteomics. In summary, this project will take advantage of the expertise of a diverse mentorship team and the world-class resources and facilities at UCSF to tackle fundamental questions in GPCR biology.
项目摘要 G蛋白偶联受体(GPCR)包括动物中最大的信号受体家族,因此, 它们代表着重要的治疗靶标。遵循配体结合和G蛋白在 质膜,GPCR会经历调节的内吞作用,并分类以进行回收或降解。传统上, 配体依赖性GPCR信号的研究集中在血浆处的受体-G蛋白偶联上 膜(PM)。但是,现在很明显GPCR可以继续从内部膜位置发出信号 并且从细胞内信号引起的下游响应与PM引起的反应不同 信号。虽然GPCR激活的生物化学已详细研究,但组织和监管 活细胞中的GPCR信号传导仍然是一个未充满活力的边界。拟议的研究将调查 GPCR信号的时空调节基础的基本机制,将提供关键 训练使Blythe博士成为分子和细胞的新兴领域的独立领导者 生理。该项目的修订阶段将在加利福尼亚大学旧金山分校进行 在GPCR贩运和信号传导领域的领导者Mark von Zastrow博士的主要心态下。 这项工作的长期目标是了解(1)GPCR的亚细胞定位如何 相关的蛋白质响应信号转导和(2)该细胞重组如何调节其 独特的下游反应。前两个目标将集中于受体运输和信号,定义 独特的内吞(AIM 1)和回收(AIM 2)途径雕刻信号传导的机制 在HEK293细胞模型中内源表达的GPCR。在进行这些实验时,Blythe博士将获得 高级成像技术以及整体膜蛋白生物化学方面的新经验 Aashish Manglik博士(合作者)的帮助。 AIM 3通过询问如何以更广泛的角度构建生物学 其他蛋白质的动态亚细胞定位有助于GPCR信号的时空调节。 在内凡·克罗根(Nevan Krogan)博士(Co-Incertor)和露丝(Ruth)的心态下,使用新颖的接近标签方法 Hüttenhain(合作者),Blythe博士将绘制特定蜂窝室蛋白质组的变化 在激活同一模型GPCR并探讨这些变化如何决定信号传导的过程中。提议 工作将实现对GPCR信号的系统级分析,而当前方法和 为基于质谱的蛋白质组学中的Blythe博士提供宝贵的培训机会。总之, 该项目将利用多元化团队和世界一流资源的专业知识以及 UCSF的设施解决GPCR生物学中的基本问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Emily Elizabeth Blythe其他文献

Emily Elizabeth Blythe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Emily Elizabeth Blythe', 18)}}的其他基金

Effects of GPCR trafficking on the spatiotemporal control of signaling
GPCR 转运对信号传导时空控制的影响
  • 批准号:
    10330369
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
  • 项目类别:
Effects of GPCR trafficking on the spatiotemporal control of signaling
GPCR 转运对信号传导时空控制的影响
  • 批准号:
    10560548
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
  • 项目类别:

相似国自然基金

β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
  • 批准号:
    81800356
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
抗β1/2肾上腺素能受体自身抗体表达增强对心房颤动的影响及机制研究
  • 批准号:
    81660053
  • 批准年份:
    2016
  • 资助金额:
    37.0 万元
  • 项目类别:
    地区科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
  • 批准号:
    81471402
  • 批准年份:
    2014
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
肾上腺素联合艾司洛尔对复苏后心肌β-肾上腺素能受体信号通路及线粒体的影响
  • 批准号:
    81372025
  • 批准年份:
    2013
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
低切应力通过β1AR-mTOR信号转导通路影响内皮细胞eNOS功能的分子机制研究
  • 批准号:
    81270191
  • 批准年份:
    2012
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
  • 批准号:
    10735460
  • 财政年份:
    2023
  • 资助金额:
    $ 12.5万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 12.5万
  • 项目类别:
Targeting the immune GPCR repertoire as a novel multimodal cancer immunotherapy strategy in oral cancer
靶向免疫 GPCR 库作为口腔癌的新型多模式癌症免疫治疗策略
  • 批准号:
    10610341
  • 财政年份:
    2022
  • 资助金额:
    $ 12.5万
  • 项目类别:
Role of Ectonucleotidase in Voiding Function and Dysfunction
外切核苷酸酶在排尿功能和功能障碍中的作用
  • 批准号:
    10292995
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
  • 项目类别:
The impact of chronic stress on radiation induced cell death and the anti-tumor immune response
慢性应激对辐射诱导的细胞死亡和抗肿瘤免疫反应的影响
  • 批准号:
    10688044
  • 财政年份:
    2021
  • 资助金额:
    $ 12.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了